Showing results (101-110 of 147) with videos related to
Sort By:
Pageof 15
Bone|July 29, 2000
Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: II. Three-dimensional histologyJ E Aaron, P A Shore, R C Shore, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1980
Pimozide: delayed onset of action at rat striatal pre- and postsynaptic dopamine receptorsB A McMillen, D C German, M K Sanghere, et al.Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1988
Pharmacology of WEB 1881-FU, a central cholinergic agent, which enhances cognition and cerebral metabolismF J Kuhn, G Schingnitz, E Lehr, et al.Arzneimittel-Forschung|January 1, 1985
Pharmacology of mifentidine, a novel H2-receptor antagonistF Pagani, R Micheletti, A Brambilla, et al.European Journal of Pharmacology|July 14, 1995
Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonistsR M Catalioto, R Porchia, A R Renzetti, et al.Peptides|September 1, 1991
Role of D-tryptophan for affinity of MEN 10207 tachykinin antagonist at NK2 receptorsP Rovero, M Astolfi, A R Renzetti, et al.Peptides|May 1, 1990
Synthesis and biological activity of NK-2 selective tachykinin antagonists containing D-tryptophanP Rovero, V Pestellini, R Patacchini, et al.Neuropeptides|June 1, 1992
Affinity of R 396, an NK-2 tachykinin receptor antagonist, for NK-2 receptors in preparations from different speciesC A Maggi, R Patacchini, M Astolfi, et al.Journal of Cardiovascular Pharmacology|March 1, 1995
Pharmacology of LR-B/057, a novel orally active AT1 receptor antagonistA R Renzetti, P Cucchi, M Guelfi, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
Binding and functional characterization of the cardioselective muscarinic antagonist methoctramineE Giraldo, R Micheletti, E Montagna, et al.Pageof 15